1. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification system: structure and principles. WHOCC. 2011. http://www.whocc.no/atc/structure_and_principles/ . Accessed 9 Jul 2016.
2. Brunton L, Chabner B, Knollman B. Goodman and Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill Education/Medical; 2011.
3. Baldessarini RJ, Cole JO, Davis JM, Gardos G. Task Force Report 18: tardive dyskinesia. Report of the American Psychiatric Association Task Force on late neurological effects of antipsychotic drugs. Washington, DC: American Psychiatric Association; 1980.
4. Lawrence RE, First MB, Lieberman JA. Schitzophrenia and other psychoses. Psychiatry Vol. 2. 4th ed. West Sussex: Wiley-Blackwell; 2015.
5. Nord M, Farde L. Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci Ther. 2011;17:97–103.